Ignite Creation Date:
2025-12-24 @ 11:08 PM
Ignite Modification Date:
2026-01-10 @ 9:41 AM
Study NCT ID:
NCT02679469
Status:
COMPLETED
Last Update Posted:
2017-04-18
First Post:
2016-01-25
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Single-center, Open-label, Single-dose Study Investigating the Safety, Tolerability, and Pharmacokinetic Properties of Nalmefene 10 mg Tablets in Healthy Japanese Male Subjects
Sponsor:
Otsuka Pharmaceutical Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-02
Start Date Type:
None
Primary Completion Date:
2016-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-03
Completion Date Type:
ACTUAL
First Submit Date:
2016-01-25
First Submit QC Date:
None
Study First Post Date:
2016-02-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-03-06
Results First Submit QC Date:
None
Results First Post Date:
2017-04-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-04-17
Last Update Post Date:
2017-04-18
Last Update Post Date Type:
ACTUAL